N/A
N=95
Promoting Cervical Cancer Screening for Emergency Department Patients
Cervical Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03483610 ↗Enrolled (actual)
95
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Number of Participants Who Scheduled or Completed Cervical Cancer Screening — 28; 21 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Provider Referral (Behavioral); Text Messaging (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- Female
- Sponsor
- University of Rochester
- Primary completion
- May 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Scheduled or Completed Cervical Cancer Screening |
28; 21 | — |
Summary
The purpose of this study is to learn methods to encourage women to get recommended cervical cancer screening. Cervical cancer screening is an important part of cervical cancer prevention. The study team will determine if the patient is currently up-to-date with cervical cancer screening recommendations. If the patient is not up-to-date, then they will be randomly assigned to one of two interventions. One intervention consists only of referral to a women's health care provider to obtain cervical cancer screening. The other intervention consists of receiving a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening.
Eligibility Criteria
Inclusion Criteria
- Registered patient in the Emergency Department of the University of Rochester Medical Center
- Women
- Age 21 - 65
Exclusion Criteria
- Past hysterectomy with cervical removal
- Known infection with HIV (screening recommendations for women with HIV differ from the general population)
- Non-English speaking
- Inability to consent
- Lack of text-capable mobile phone and/or inability to use text function
Data sourced from ClinicalTrials.gov (NCT03483610). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.